Linked Data API

Show Search Form

Search Results

1689862
star this property registered interest false more like this
star this property date less than 2024-02-19more like thismore than 2024-02-19
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many people aged under 18 have been prescribed medicinal cannabis as of 19 February 2024. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 14583 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-02-27more like thismore than 2024-02-27
unstar this property answer text <p>The Department does not hold details relating to the age of people prescribed medicinal cannabis.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-02-27T11:18:22.867Zmore like thismore than 2024-02-27T11:18:22.867Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1689392
star this property registered interest false more like this
star this property date less than 2024-02-16more like thismore than 2024-02-16
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans her Department has to make medicinal cannabis more accessible to those who need it. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Paula Barker more like this
star this property uin 14291 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-02-21more like thismore than 2024-02-21
unstar this property answer text <p>Licensed cannabis-based medicines are routinely available on the National Health Service. However, clinical guidelines from the National Institute for Health and Care Excellence (NICE) demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines.</p><p> </p><p>The Government continues to call on manufacturers to invest in research and clinical trials to prove if their products are safe and effective and offers scientific and research advice from the Medicines and Healthcare products Regulatory Agency and the NICE.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-02-21T09:43:53.517Zmore like thismore than 2024-02-21T09:43:53.517Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4828
unstar this property label Biography information for Paula Barker more like this
1687065
star this property registered interest false more like this
star this property date less than 2024-02-02more like thismore than 2024-02-02
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress she has made with (a) regulatory, (b) research and (c) NHS partners on establishing clinical trials to test the (i) safety and (ii) efficacy of medical cannabis products. more like this
star this property tabling member constituency Somerton and Frome more like this
star this property tabling member printed
Sarah Dyke more like this
star this property uin 12872 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-02-09more like thismore than 2024-02-09
unstar this property answer text <p>The Department, via the National Institute for Health and Care Research (NIHR), is developing a programme of two randomised controlled trials to test the safety and efficacy of medicinal cannabis products to treat epilepsy in adults and children. The trials will start as soon as possible, and the results will be published once the trials have completed and the findings peer reviewed.</p><p> </p><p>Furthermore, the Government continues to encourage manufacturers to invest in research and has highlighted that public funding is available for high quality applications. The Medicines and Healthcare products Regulatory Agency and the NIHR can provide applicants with scientific and research advice.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-02-09T10:47:53.36Zmore like thismore than 2024-02-09T10:47:53.36Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4995
unstar this property label Biography information for Sarah Dyke more like this
1682606
star this property registered interest false more like this
star this property date less than 2024-01-16more like thismore than 2024-01-16
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the potential merits of allowing children to be issued medical cannabis prescriptions on the NHS. more like this
star this property tabling member constituency Somerton and Frome more like this
star this property tabling member printed
Sarah Dyke more like this
star this property uin 9974 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-01-22more like thismore than 2024-01-22
unstar this property answer text <p>Licensed cannabis-based medicines, that have been proved effective in clinical trials and judged cost-effective by the National Institute of Health and Care Excellence (NICE), are routinely available on the National Health Service, including for people aged over two years old with certain types of epilepsy. However, clinical guidelines from NICE demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines.</p><p>We continue to call on manufacturers to conduct research to prove if their products are safe and effective and we are working with regulatory, research and NHS partners to establish clinical trials to test the safety and efficacy of these products.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-01-22T14:04:14.56Zmore like thismore than 2024-01-22T14:04:14.56Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4995
unstar this property label Biography information for Sarah Dyke more like this
1681903
star this property registered interest false more like this
star this property date less than 2024-01-15more like thismore than 2024-01-15
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if she will make an assessment of the effectiveness of medicinal cannabis treatments provided by the NHS; and whether she has plans to increase the number of treatments available. more like this
star this property tabling member constituency Romford more like this
star this property tabling member printed
Andrew Rosindell more like this
star this property uin 9453 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-01-17more like thismore than 2024-01-17
unstar this property answer text <p>Licensed cannabis-based medicines are available and funded on the National Health Service, where the safety, quality and clinical and cost effectiveness has been assessed and approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence.</p><p>The Government continues to encourage manufacturers to develop new treatments and invest in research and clinical trials, and offers scientific and research advice from the MHRA and the National Institute for Health and Care Research.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-01-17T17:12:08.693Zmore like thismore than 2024-01-17T17:12:08.693Z
star this property answering member
4044
star this property label Biography information for Andrew Stephenson more like this
star this property tabling member
1447
unstar this property label Biography information for Andrew Rosindell more like this
1681904
star this property registered interest false more like this
star this property date less than 2024-01-15more like thismore than 2024-01-15
star this property answering body
Department for Business and Trade more like this
unstar this property answering dept id 214 more like this
star this property answering dept short name Business and Trade more like this
star this property answering dept sort name Business and Trade more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State of Business and Trade, what estimate she has made of the contribution of domestic medicinal cannabis production to the economy. more like this
star this property tabling member constituency Romford more like this
star this property tabling member printed
Andrew Rosindell more like this
star this property uin 9454 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2024-01-23more like thismore than 2024-01-23
unstar this property answer text <p>The Department for Business and Trade (DBT) actively assists life sciences companies in their endeavours to invest, expand, and export, thereby generating employment and economic growth.</p><p>UK-based life sciences businesses receive support from DBT through trade missions to key markets, participation in major trade events, tackling market access barriers, upskilling exporters, and guidance on entering new markets. Although routine assessments of the economic impact of specific life sciences’ subsectors like medicinal cannabis are not conducted, DBT is committed to supporting companies of various sizes throughout their export and inward investment endeavours while adhering to national regulatory guidelines.</p> more like this
star this property answering member constituency Thirsk and Malton more like this
star this property answering member printed Kevin Hollinrake more like this
star this property question first answered
less than 2024-01-23T17:59:05.127Zmore like thismore than 2024-01-23T17:59:05.127Z
star this property answering member
4474
star this property label Biography information for Kevin Hollinrake more like this
star this property tabling member
1447
unstar this property label Biography information for Andrew Rosindell more like this
1663633
star this property registered interest false more like this
star this property date less than 2023-10-13more like thismore than 2023-10-13
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether the Government is taking steps to reduce inequalities in access to medicinal cannabis prescribed under the NHS. more like this
star this property tabling member constituency York Outer more like this
star this property tabling member printed
Julian Sturdy more like this
star this property uin 201487 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-10-19more like thismore than 2023-10-19
unstar this property answer text <p>Licensed cannabis-based medicines are routinely available on the National Health Service. However, clinical guidelines from the National Institute for Health and Care Excellence demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines.</p><p>Funding of unlicensed products is subject to local National Health Service decisions on a case-by-case basis. These decisions follow clearly developed procedures that ensure equitable distribution of funding, prioritising those medicines that have proved their safety, quality, and clinical and cost effectiveness.</p><p>We continue to call on manufacturers to conduct research to prove if their products are safe and effective and we are working with regulatory, research and NHS partners to establish clinical trials to test the safety and efficacy of these products.</p> more like this
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-10-19T14:43:27.227Zmore like thismore than 2023-10-19T14:43:27.227Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1663778
star this property registered interest false more like this
star this property date less than 2023-10-13more like thismore than 2023-10-13
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will take steps to increase access to cannabis-based medicinal products on the NHS. more like this
star this property tabling member constituency Ealing Central and Acton more like this
star this property tabling member printed
Dr Rupa Huq more like this
star this property uin 201631 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-10-19more like thismore than 2023-10-19
unstar this property answer text <p>Licensed cannabis-based medicines are routinely available on the National Health Service. However, clinical guidelines from the National Institute for Health and Care Excellence demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines.</p><p>Funding of unlicensed products is subject to local NHS decisions on a case-by-case basis. These decisions follow clearly developed procedures that ensure equitable distribution of funding, prioritising those medicines that have proved their safety, quality and clinical and cost effectiveness.</p><p>We continue to call on manufacturers to conduct research to prove if their products are safe and effective and we are working with regulatory, research and NHS partners to establish clinical trials to test the safety and efficacy of these products.</p> more like this
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-10-19T11:14:45.24Zmore like thismore than 2023-10-19T11:14:45.24Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4511
unstar this property label Biography information for Dr Rupa Huq more like this
1652383
star this property registered interest false more like this
star this property date less than 2023-07-12more like thismore than 2023-07-12
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will meet members of the Medcan Family Foundation to discuss the availability of advanced unlicensed medicinal cannabis for those people who had been diagnosed with childhood epilepsy. more like this
star this property tabling member constituency Christchurch more like this
star this property tabling member printed
Sir Christopher Chope more like this
star this property uin 193547 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-07-17more like thismore than 2023-07-17
unstar this property answer text <p>Health Ministers have met with families and patients and have discussed the challenges around the use of unlicensed cannabis-based medicines at great length in Parliament., Ministers are focused on galvanising research to determine if these products are safe and effective and might be funded within the National Health Service.</p><p>The National Institute for Health and Care Research and NHS England will be supporting two world-first randomised control trials on cannabinoids in the treatment of epilepsy. When further details on the trials is available, we will ensure the Medcan Family Foundation are informed.</p> more like this
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-07-17T14:51:28.273Zmore like thismore than 2023-07-17T14:51:28.273Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
242
unstar this property label Biography information for Sir Christopher Chope more like this
1642217
star this property registered interest false more like this
star this property date less than 2023-06-06more like thismore than 2023-06-06
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments remove filter
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the (a) quality and (b) safety of imported cannabis-based products for medicinal use; if he will make a statement. more like this
star this property tabling member constituency North Herefordshire more like this
star this property tabling member printed
Sir Bill Wiggin more like this
star this property uin 187907 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-06-14more like thismore than 2023-06-14
unstar this property answer text <p>Cannabis based products for medicinal use in humans (CBPMs) is a term that usually designates medicinal products that are not licensed in the United Kingdom. Most CBPMs in use in the UK are unlicensed medicines imported into the Country. Regulation 167 of the Human Medicine Regulations 2012, as amended, allows for medicines without a marketing authorisation, also referred to as a licence, to be supplied under certain circumstances. In the interest of public health, the exemption is narrowly drawn because unlicensed medicines or specials, unlike licensed medicinal products, have not been assessed by the Licensing Authority against the criteria of safety, quality and efficacy.</p><p>An unlicensed medicine may be supplied following a bona fide unsolicited order and is formulated in accordance with the specific requirements of the prescriber. This means that the quality, safety and efficacy of unlicensed medicines is the direct responsibility of the prescribers responsible for the care of individual patients as they are the ones that determine if these are fit for purpose.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) ensures that any importer of an unlicensed medicinal product into the UK must be suitably licensed to import unlicensed medicines and prior to the importation taking place the importer must notify of their intent to import the unlicensed medicine and provide a set of supportive documentation, which the MHRA will assess to ensure the medicine’s quality and safety. This typically includes the requirement that a medicine has been produced in facilities meeting Good Manufacturing Practice or equivalent recognised quality standards for medicines.</p>
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-06-14T16:50:18.487Zmore like thismore than 2023-06-14T16:50:18.487Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
1428
unstar this property label Biography information for Sir Bill Wiggin more like this